Cleared Traditional

K202800 - Pacific Plus PTA Catheter

K202800 is the FDA 510(k) clearance for Pacific Plus PTA Catheter by Medtronic Vascular,Inc(Formerly D.B.A Ev3 Inc.,Covidien, LLC). It is a Class 2 Cardiovascular device (product code LIT) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K202800 · Medtronic Vascular,Inc(Formerly D.B.A Ev3 Inc.,Covidien, LLC) · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
56d
Days
Class 2
Risk

K202800 is an FDA 510(k) clearance for the Pacific Plus PTA Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Medtronic Vascular,Inc(Formerly D.B.A Ev3 Inc.,Covidien, LLC) (Plymouth, US). The FDA issued a Cleared decision on November 18, 2020 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic Vascular,Inc(Formerly D.B.A Ev3 Inc.,Covidien, LLC) devices

Submission Details

510(k) Number K202800 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2020
Decision Date November 18, 2020
Days to Decision 56 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 125d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 238
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K202800.
Sublime Radial Access 018 RX Dilatation Catheter
K211044 · Creagh Medical Ltd. (A Wholly Owned Subsidiary of Surmodics, · Jun 2021
SABER .035 Percutaneous Transluminal Angioplasty (PTA) Dilatation Catheter
K210626 · Cordis Corporation · Apr 2021
JADE
K202231 · OrbusNeich Medical (Shenzhen) Co., Ltd. · Dec 2020
SABERX RADIANZ Percutaneous Transluminal Angioplasty Dilatation Catheter
K201377 · Cordis Corporation · Oct 2020
Athletis PTA Balloon Dilatation Catheter
K201170 · Boston Scientific Corporation · Sep 2020
SABER .035 PTA Dilatation Catheter
K201333 · Cordis Corporation · Sep 2020